| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |